-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Zura Bio, Lowers Price Target to $8

Benzinga·11/10/2026 13:53:28
Listen to the news
Guggenheim analyst Yatin Suneja maintains Zura Bio (NASDAQ:ZURA) with a Buy and lowers the price target from $20 to $8.